Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOS in Advanced Gastric Cancer
NCT00525005Phase 2Completed
- Sponsor
- Hallym University Medical Center
- Start
- Aug 2007
- Primary completion
- Jun 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, oxaliplatin, tegafur in gastric adenocarcinoma, sponsored by Hallym University Medical Center. Started Aug 2007; status: completed.
02
Drugs
docetaxeloxaliplatintegafur
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT00525005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00525005.